Further functional validation is necessary to clarify the mechanistic interplay between KCa3.1 and its interacting partners, particularly in pathways related to tumor invasion, immune evasion, and drug resistance, and to nail down the specific role of mitochondrial KCa3.1 in cancer‐related processes. This evidence concerns the gene KCNN4 and cancer.